Stock UniverseDerived research view · source repositories remain read-only

ResMed Inc. (RMD)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Instruments & Supplies
Score Band
High
Selection Score
41.49
Global Rank
272
Market Cap
37.33B
Latest Close
196.04
RS Composite
-23.52% · G#2804

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-6.21%
3M
-22.24%
6M
-21.62%
1Y
-20.80%
3Y
-4.24%
5Y
-0.48%
10Y
271.48%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.26M · 30-day average: 1.60M · Max drawdown over stored range: -53.99%

Research Snapshot

Relative Strength vs SPX

RS Composite-23.52%
20D RS-5.60%
60D RS-27.10%
120D RS-28.91%
Global RS Rank2804 · 16.42% percentile
Qualified+ RS Rank1092 · 13.20% percentile
Group ScopeQualified+
Primary RS Rank116 · 18.31% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank26 / 246
Primary Percentile89.84
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-015.54B3.41B1.89B1.52B10.373.14B250.21M2.89B147M61.59%34.18%27.44%56.78%52.26%1.66B664.10M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$10.3718.9x$37.805.2x$19.759.9x$21.469.1x

Shares Diluted: 147M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue3196.8253578.1274222.9934685.2975146.327
Revenue Growth (YoY)8.11%11.928%18.022%10.947%9.84%
Gross Profit1889.4272063.9612386.0582688.2663087.086
Operating Income917.5511002.151151.9971384.1211687.394
Free Cash Flow634.006216.312573.6271301.81661.723
Free Cash Flow Per Share4.3291.4713.898.82311.278
EPS (Diluted) GAAP3.245.36.096.929.51
EPS Growth-24.122%63.58%14.906%13.629%37.428%
EPS Non-GAAP
Gross Margin59.103%57.683%56.502%57.377%59.986%
Operating Margin28.702%28.008%27.279%29.542%32.788%
Profit Margin14.843%21.783%21.254%21.791%27.218%
Free Cash Flow Margin19.832%6.045%13.583%27.785%32.289%
Shares Outstanding (Diluted)146.451147.043147.455147.55147.34
Shares Change (YoY)0.549%0.404%0.28%0.064%-0.142%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q32026-05-011.43B62.25%499.81M34.92%398.73M27.86%2.74145.72M1.66B664.10Mprocessed
2026 Q22026-01-301.42B61.76%491.66M34.56%392.59M27.59%2.68146.37M1.42B663.83Mprocessed
2026 Q12025-10-311.34B61.46%446.54M33.43%348.54M26.10%2.37146.90M1.38B668.56Mprocessed
2025 Q42025-08-081.35B60.84%454.54M33.72%379.70M28.17%2.58147.06M1.21B668.29Mprocessed
2025 Q32025-04-241.29B59.33%426.27M33.00%365.04M28.26%2.48147.22M932.71M673.03Mprocessed
2025 Q22025-01-311.28B58.60%417.24M32.54%344.62M26.88%2.34147.48M521.94M672.76Mprocessed
2025 Q12024-10-251.22B58.57%387.31M31.63%311.36M25.43%2.11147.60M426.36M677.47Mprocessed
2024 Q42024-08-091.22B58.50%381.22M31.17%292.24M23.89%1.98147.55M238.36M707.21Mprocessed
2024 Q32024-04-261.20B57.88%374.58M31.29%300.49M25.10%2.04147.45M237.91M1.01Bprocessed
2024 Q22024-01-251.16B55.64%275.09M23.66%208.80M17.96%1.42147.54M210.25M1.23Bprocessed
2024 Q12023-10-271.10B54.44%289.00M26.22%219.42M19.91%1.49147.49M209.10M1.36Bprocessed
2023 Q42023-08-111.12B55.02%275.27M24.53%229.66M20.47%1.56147.62M227.89M1.44Bprocessed
2023 Q32023-04-281.12B55.31%300.67M26.92%232.50M20.82%1.58147.40M227.89M1.59Bprocessed
2023 Q22023-01-271.03B56.08%280.19M27.10%224.91M21.76%1.53147.41M253.20M1.80Bprocessed
2023 Q12022-10-28950.29M56.91%275.74M29.02%210.48M22.15%1.43147.13M207.16M795.34Mprocessed
2022 Q42022-08-12914.74M57.12%255.40M27.92%195.06M21.32%1.33147.07M273.71M775.24Mprocessed
2022 Q32022-04-29864.50M56.82%234.26M27.10%179.01M20.71%1.22146.96M201.77M680.70Mprocessed
2022 Q22022-01-28894.87M56.36%248.71M27.79%201.75M22.55%1.37147.04M194.48M679.98Mprocessed
2022 Q12021-10-29904.01M56.00%261.91M28.97%203.61M22.52%1.39146.86M276.15M805.67Mprocessed
2021 Q42021-08-17876.10M56.01%241.64M27.58%195.10M22.27%1.33146.62M295.28M655.35Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.